Roman Butler Fullerton & CO Bristol Myers Squibb CO Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 13,978 shares of BMY stock, worth $806,251. This represents 0.22% of its overall portfolio holdings.

Number of Shares

13,978

Previous 13,328 4.88%

Holding current value

$806,251

Previous $553,000 30.74%

% of portfolio

0.22%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$39.66 - $51.75 $25,778 - $33,637	650 Added 4.88%	13,978 $723,000
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $72,852 - $95,911	-1,810 Reduced 11.96%	13,328 $553,000
Q1 2024 Apr 29, 2024	SELL	$47.98 - $54.4 $109,922 - $124,630	-2,291 Reduced 13.14%	15,138 $820,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $80,088 - $95,568	-1,652 Reduced 8.66%	17,429 $894,000
Q2 2023 Jul 25, 2023	SELL	$63.71 - $70.74 $122,004 - $135,467	-1,915 Reduced 9.12%	19,081 $1.22 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $50,071 - $56,791	762 Added 3.77%	20,996 $1.46 Million
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $3,834 - $4,541	-56 Reduced 0.28%	20,234 $0
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $12 - $7,376	96 Added 0.48%	20,290 $1.41 Million
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $3,050 - $3,359	42 Added 0.21%	20,194 $1.53 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $37,318 - $44,748	-607 Reduced 2.92%	20,152 $1.47 Million
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $4,773 - $5,564	-89 Reduced 0.43%	20,759 $1.29 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $185,202 - $216,940	3,130 Added 17.67%	20,848 $1.19 Million
Q2 2021 Jul 29, 2021	BUY	$61.91 - $67.42 $6,129 - $6,674	99 Added 0.56%	17,718 $1.18 Million
Q1 2021 Apr 22, 2021	SELL	$59.34 - $66.74 $890 - $1,001	-15 Reduced 0.09%	17,619 $1.14 Million
Q4 2020 Feb 01, 2021	BUY	$57.74 - $65.43 $5,716 - $6,477	99 Added 0.56%	17,634 $1.09 Million
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $31,184 - $34,556	-543 Reduced 3.0%	17,535 $1.06 Million
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $1,315 - $1,538	-24 Reduced 0.13%	18,078 $1.06 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $9,744 - $14,160	-210 Reduced 1.15%	18,102 $1.01 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $14,221 - $18,550	289 Added 1.6%	18,312 $1.18 Million
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $5,132 - $6,085	120 Added 0.67%	18,023 $914,000
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $5,666 - $6,266	-127 Reduced 0.7%	17,903 $812,000
Q1 2019 Apr 24, 2019	BUY	$45.12 - $53.8 $11,009 - $13,127	244 Added 1.37%	18,030 $860,000
Q4 2018 Feb 04, 2019	BUY	$48.76 - $63.23 $867,245 - $1.12 Million	17,786 New	17,786 $849,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Bristol Myers Squibb CO Transaction History